Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ERASErasca, Inc.

Nasdaq · CIK 0001761918
Filer category<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts205

Identity from submissions API

NameErasca, Inc.
CIK0001761918
TickersERAS
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN831217027
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(858) 465-6511
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
3115 MERRYFIELD ROW
THIRD FLOOR
SAN DIEGO
CA
92121
CA
Mailing address
3115 MERRYFIELD ROW
THIRD FLOOR
SAN DIEGO
CA
92121
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

358 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 8-K 8-K 8.01 0001193125-26-469283 001-40602 261576669 34 246331 1 1
2026-11-16 144 xsl144X01/primary_doc.xml 0001628280-26-074061 001-40602 261558355 33 6830
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001897612-26-000747 005-92728 261556559 34 7705
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493215-26-000188 005-92728 261555589 34 10329
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-458350 001-40602 261546939 34 346244 1 1
2026-11-12 10-Q 10-Q 0001193125-26-458289 001-40602 261546722 34 23420873 1 1
2026-10-16 8-K 8-K 5.02 0001193125-26-423433 001-40602 261464435 34 149957 1 1
2026-10-15 144 xsl144X01/primary_doc.xml 0001628280-26-065966 001-40602 261462276 33 6983
2026-09-15 144 xsl144X01/primary_doc.xml 0001628280-26-062070 001-40602 261381396 33 6983
2026-08-24 8-K 8-K 8.01 0001193125-26-361895 001-40602 261306390 34 155203 1 1
2026-08-17 144 xsl144X01/primary_doc.xml 0001628280-26-057296 001-40602 261286241 33 6286
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-352396 005-92728 261282446 34 10671
2026-08-12 4 4 0001193125-26-346924 6287
2026-08-12 3 3 0001193125-26-346920 3136
2026-08-11 S-8 S-8 0001193125-26-344845 333-298234 261263913 33 382171 1 1
2026-08-11 10-Q 10-Q 0001193125-26-344611 001-40602 261263210 34 23043153 1 1
2026-08-11 8-K 8-K 2.02,9.01 0001193125-26-344584 001-40602 261263121 34 352332 1 1
2026-08-10 8-K 8-K 5.02 0001193125-26-342669 001-40602 261259522 34 164667 1 1
2026-07-21 144 xsl144X01/primary_doc.xml 0001628280-26-048993 001-40602 261190234 33 6285
2026-07-14 8-K 8-K 8.01,9.01 0001193125-26-303357 001-40602 261174918 34 499247 1 1
2026-07-14 424B5 424B5 0001193125-26-303352 333-297427 261174909 33 680906 1 1
2026-07-13 424B5 424B5 0001193125-26-302148 333-297427 261172056 33 545687
2026-07-13 8-K 8-K 8.01 0001193125-26-302045 001-40602 261171532 34 174762 1 1
2026-07-13 S-3ASR S-3ASR 0001193125-26-302035 333-297427 261171507 33 772650 1 1
2026-07-01 8-K 8-K 5.07 0001193125-26-290881 001-40602 261141851 34 165007 1 1
2026-06-29 4 4 0001193125-26-288910 5378
2026-06-29 4 4 0001193125-26-288908 5309
2026-06-29 4 4 0001193125-26-288906 5382
2026-06-29 4 4 0001193125-26-288905 5371
2026-06-29 4 4 0001193125-26-288903 5378
2026-06-29 4 4 0001193125-26-288902 5375
2026-06-15 144 xsl144X01/primary_doc.xml 0001628280-26-043327 001-40602 261092208 33 6983
2026-05-15 144 xsl144X01/primary_doc.xml 0001628280-26-035691 001-40602 26989121 33 6979
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001738048-26-000060 005-92728 26988704 34 17871
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062612 005-92728 26988206 34 12505
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001897612-26-000492 005-92728 26983416 34 7625
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493215-26-000106 005-92728 26982504 34 12539
2026-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-002900 005-92728 26970236 34 17265
2026-05-11 10-Q 10-Q 0001193125-26-216788 001-40602 26963351 34 17707024 1 1
2026-05-11 8-K 8-K 2.02,9.01 0001193125-26-216739 001-40602 26963124 34 297388 1 1
2026-04-28 ARS ARS 0001193125-26-187422 001-40602 26908796 34 1984597
2026-04-28 DEFA14A DEFA14A 0001193125-26-187382 001-40602 26908681 34 111818
2026-04-28 DEF 14A DEF 14A 0001193125-26-187361 001-40602 26908662 34 1214943 1 1
2026-04-27 8-K 8-K 8.01 0001193125-26-182137 001-40602 26901292 34 1303094 1 1
2026-04-27 8-K 8-K 7.01,8.01 0001193125-26-179214 001-40602 26896697 34 158428 1 1
2026-04-21 8-K 8-K 8.01 0001193125-26-165297 001-40602 26876928 34 151982 1 1
2026-04-15 144/A xsl144X01/primary_doc.xml 0001628280-26-025296 001-40602 26864949 33 7073
2026-04-15 144 xsl144X01/primary_doc.xml 0001628280-26-025291 001-40602 26864844 33 6854
2026-04-03 4 4 0001193125-26-141395 8985
2026-04-01 144 xsl144X01/primary_doc.xml 0001628280-26-022734 001-40602 26826980 33 4992
2026-03-16 144 xsl144X01/primary_doc.xml 0001628280-26-018080 001-40602 26755993 33 6433
2026-03-12 10-K 10-K 0001193125-26-104150 001-40602 26747810 34 51996191 1 1
2026-03-12 8-K 8-K 2.02,9.01 0001193125-26-104105 001-40602 26747619 34 350700 1 1
2026-03-06 4 4 0001193125-26-095181 8865
2026-03-04 144 xsl144X01/primary_doc.xml 0001628280-26-014764 001-40602 26722989 33 4332
2026-02-17 144 xsl144X01/primary_doc.xml 0001628280-26-008468 001-40602 26639747 33 6432
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001897612-26-000279 005-92728 26637759 34 7509
2026-01-30 4 4 0001193125-26-030626 5389
2026-01-30 4 4 0001193125-26-030624 7051
2026-01-30 4 4 0001193125-26-030619 5327
2026-01-30 4 4 0001193125-26-030617 5281
2026-01-30 4 4 0001193125-26-030615 5319
2026-01-29 8-K 8-K 8.01 0001193125-26-029467 001-40602 26578536 34 155359 1 1
2026-01-22 8-K 8-K 8.01,9.01 0001193125-26-019651 001-40602 26552460 34 486884 1 1
2026-01-22 424B5 424B5 0001193125-26-019641 333-289537 26552443 33 556955
2026-01-20 8-K 8-K 2.02 0001193125-26-016556 001-40602 26542837 34 142784 1 1
2026-01-20 424B5 424B5 0001193125-26-016549 333-289537 26542802 33 558728
2026-01-15 144 xsl144X01/primary_doc.xml 0001628280-26-002131 001-40602 26535092 33 6432
2026-01-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-003756 005-92728 26533607 34 15928
2026-01-12 8-K 8-K 7.01,8.01,9.01 0001193125-26-009820 001-40602 26524741 34 17947698 1 1
2026-01-08 4 4 0001193125-26-008076 10314
2026-01-07 144 xsl144X01/primary_doc.xml 0001628280-26-001146 001-40602 26515582 33 4365
2026-01-05 4 4 0001193125-26-001611 5631
2026-01-05 4 4 0001193125-26-001610 5565
2026-01-05 4 4 0001193125-26-001609 5638
2026-01-05 4 4 0001193125-26-001608 5634
2026-01-05 4 4 0001193125-26-001606 5627
2025-12-15 144 xsl144X01/primary_doc.xml 0001628280-25-057210 001-40602 251573059 33 6431
2025-11-17 144 xsl144X01/primary_doc.xml 0001628280-25-052617 001-40602 251491383 33 6474
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000678 005-92728 251483785 34 15533
2025-11-12 10-Q 10-Q 0001193125-25-277625 001-40602 251472983 34 12667217 1 1
2025-11-12 8-K 8-K 2.02,9.01 0001193125-25-277571 001-40602 251472758 34 333709 1 1
2025-10-15 144 xsl144X01/primary_doc.xml 0001628280-25-045091 001-40602 251394769 33 6473
2025-09-15 144 xsl144X01/primary_doc.xml 0001973524-25-000005 001-40602 251314588 33 6473
2025-08-22 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002722 333-289537 251247801 33 1740
2025-08-20 CORRESP filename1.htm 0001193125-25-184070 6714
2025-08-18 UPLOAD filename1.pdf 0000000000-25-008699 333-289537 40121
2025-08-15 144 xsl144X01/primary_doc.xml 0002007317-25-000883 001-40602 251224307 33 6450
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000535 005-92728 251220577 34 15301
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-021783 005-92728 251216825 34 35414
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001897612-25-000379 005-92728 251216270 34 7510
2025-08-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-25-004725 005-92728 251213742 34 16925
2025-08-12 S-3 S-3 0001193125-25-179038 333-289537 251207475 33 1174544 1 1
2025-08-12 10-Q 10-Q 0001193125-25-178996 001-40602 251207149 34 12691292 1 1
2025-08-12 8-K 8-K 2.02,9.01 0001193125-25-178950 001-40602 251206714 34 332007 1 1
2025-07-15 144 xsl144X01/primary_doc.xml 0002007317-25-000717 001-40602 251124630 33 6417
2025-06-26 8-K 8-K 5.07 0000950170-25-090493 001-40602 251081200 34 165268 1 1
2025-06-26 4 4 0000950170-25-090426 5219
2025-06-26 4 4 0000950170-25-090424 5152
2025-06-26 4 4 0000950170-25-090423 5221
2025-06-26 4 4 0000950170-25-090422 5221
2025-06-26 4 4 0000950170-25-090420 5225
2025-06-26 4 4 0000950170-25-090418 5218
2025-06-26 4 4 0000950170-25-090415 5214
2025-06-16 144 xsl144X01/primary_doc.xml 0002007317-25-000579 001-40602 251049790 33 6417
2025-06-03 4 4 0000950170-25-080941 6282
2025-05-15 144 xsl144X01/primary_doc.xml 0002007317-25-000398 001-40602 25953362 33 6415
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-012990 005-92728 25949408 34 57609
2025-05-13 10-Q 10-Q 0000950170-25-070418 001-40602 25940529 34 11363291 1 1
2025-05-13 8-K 8-K 2.02,9.01 0000950170-25-070336 001-40602 25940151 34 292152 1 1
2025-04-29 ARS ARS 0001193125-25-103908 001-40602 25888291 34 11489169
2025-04-29 DEFA14A DEFA14A 0001193125-25-103883 001-40602 25888180 34 179189
2025-04-29 DEF 14A DEF 14A 0001193125-25-103868 001-40602 25888101 34 1324772 1 1
2025-04-15 144 xsl144X01/primary_doc.xml 0001971857-25-000194 001-40602 25839393 33 6266
2025-03-20 10-K 10-K 0000950170-25-042682 001-40602 25756701 34 63480159 1 1
2025-03-20 8-K 8-K 2.02,9.01 0000950170-25-042659 001-40602 25756522 34 346699 1 1
2025-03-17 144 xsl144X01/primary_doc.xml 0002002698-25-000094 001-40602 25745184 33 6283
2025-02-18 144 xsl144X01/primary_doc.xml 0002007317-25-000161 001-40602 25634688 33 6289
2025-02-18 4 4 0000950170-25-021831 5257
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-25-001292 005-92728 25622482 34 16886
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-012252 005-92728 25615863 34 45093
2025-02-05 4 4 0000950170-25-014197 8632
2025-02-05 4 4 0000950170-25-014195 5267
2025-02-05 4 4 0000950170-25-014194 8626
2025-02-05 4 4 0000950170-25-014192 5329
2025-01-15 144 xsl144X01/primary_doc.xml 0002007317-25-000008 001-40602 25532549 33 6284
2025-01-13 8-K 8-K 7.01,9.01 0000950170-25-004613 001-40602 25525070 34 28850266 1 1
2025-01-02 4 4 0000950170-25-000639 5612
2025-01-02 4 4 0000950170-25-000637 5550
2025-01-02 4 4 0000950170-25-000635 5619
2025-01-02 4 4 0000950170-25-000630 5616
2024-12-16 144 xsl144X01/primary_doc.xml 0001971857-24-000872 001-40602 241552815 33 6284
2024-11-15 144 xsl144X01/primary_doc.xml 0002007317-24-000632 001-40602 241467234 33 6284
2024-11-14 SC 13G/A ARCH VENTURE FUND X, L.P. - ERASCA, INC. -- SCH 13G/A(#1E) 0001072613-24-000884 005-92728 241464239 34 80501
2024-11-14 SC 13G/A armistice-eras093024a1.htm 0001172661-24-005163 005-92728 241461719 34 90578
2024-11-14 SC 13G eras13gsep24.txt 0001897612-24-001982 005-92728 34 6456
2024-11-12 10-Q 10-Q 0000950170-24-125481 001-40602 241448595 34 10040537 1 1
2024-11-12 8-K 8-K 2.02,9.01 0000950170-24-125337 001-40602 241447935 34 308013 1 1
2024-11-08 SC 13G us29479a1088_110824.txt 0002012383-24-003610 005-92728 241439733 34 13679
2024-10-29 SC 13G/A SC 13G/A 0001193125-24-246753 005-92728 241407122 34 73962
2024-10-24 SC 13G us29479a1088_102424.txt 0002012383-24-002198 005-92728 241392075 34 13665
2024-10-24 8-K 8-K 8.01 0000950170-24-116856 001-40602 241390789 34 164627 1 1
2024-10-15 144 xsl144X01/primary_doc.xml 0001971857-24-000668 001-40602 241371358 33 6285
2024-09-16 144 xsl144X01/primary_doc.xml 0002002698-24-000426 001-40602 241301151 33 6285
2024-08-15 144 xsl144X01/primary_doc.xml 0002002698-24-000203 001-40602 241211452 33 6288
2024-08-12 10-Q 10-Q 0000950170-24-095437 001-40602 241196898 34 11191933 1 1
2024-08-12 8-K 8-K 2.02,9.01 0000950170-24-095408 001-40602 241196744 34 310013 1 1
2024-07-15 144 xsl144X01/primary_doc.xml 0001971857-24-000523 001-40602 241116688 33 6334
2024-06-24 8-K 8-K 5.07 0000950170-24-076476 001-40602 241062244 34 163958 1 1
2024-06-24 8-K 8-K 8.01 0000950170-24-076474 001-40602 241062234 34 156894 1 1
2024-06-21 4 FORM 4 SUBMISSION 0001209191-24-005929 5454
2024-06-21 4 FORM 4 SUBMISSION 0001209191-24-005928 5456
2024-06-21 4 FORM 4 SUBMISSION 0001209191-24-005927 5387
2024-06-21 4 FORM 4 SUBMISSION 0001209191-24-005926 5488
2024-06-21 4 FORM 4 SUBMISSION 0001209191-24-005925 5496
2024-06-21 4 FORM 4 SUBMISSION 0001209191-24-005924 5557
2024-06-21 4 FORM 4 SUBMISSION 0001209191-24-005923 5491
2024-06-21 4 FORM 4 SUBMISSION 0001209191-24-005922 5456
2024-06-21 4 FORM 4 SUBMISSION 0001209191-24-005921 5449
2024-06-21 4 FORM 4 SUBMISSION 0001209191-24-005920 5453
2024-06-21 4 FORM 4 SUBMISSION 0001209191-24-005919 5460
2024-06-17 144 xsl144X01/primary_doc.xml 0001971857-24-000415 001-40602 241047884 33 6339
2024-05-31 SC 13G SC 13G 0001104659-24-067180 005-92728 241009932 34 181797
2024-05-29 SC 13G SC 13G 0001193125-24-148846 005-92728 24995837 34 333639
2024-05-28 SC 13G d11056386_13-g.htm 0000919574-24-003350 005-92728 24992480 34 108777
2024-05-22 4 FORM 4 SUBMISSION 0001209191-24-005689 5911
2024-05-17 424B5 424B5 0001193125-24-141858 333-266802 24961206 33 444469
2024-05-17 8-K 8-K 8.01,9.01 0001193125-24-141066 001-40602 24957615 34 467909 1 1
2024-05-16 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-05-16 16:00:00 9999999995-24-001559 333-279261 24957588 33 1724
2024-05-16 8-K 8-K 1.01,2.05,8.01,9.01 0001193125-24-140591 001-40602 24955922 34 22085558 1 1
2024-05-15 144 xsl144X01/primary_doc.xml 0001971857-24-000225 001-40602 24949923 33 6329
2024-05-14 CORRESP filename1.htm 0001193125-24-138188 6585
2024-05-14 UPLOAD filename1.pdf 0000000000-24-005503 333-279261 40290
2024-05-09 S-3 S-3 0001193125-24-135289 333-279261 24930980 33 276963
2024-05-09 S-8 S-8 0001193125-24-135276 333-279257 24930811 33 92566
2024-05-08 10-Q 10-Q 0000950170-24-055668 001-40602 24926208 34 8452190 1 1
2024-05-08 8-K 8-K 2.02,9.01 0000950170-24-055644 001-40602 24926048 34 271915 1 1
2024-04-26 ARS ARS 0001193125-24-118113 001-40602 24884079 34 3688192
2024-04-26 DEFA14A DEFA14A 0001193125-24-118067 001-40602 24883910 34 433190
2024-04-26 DEF 14A DEF 14A 0001193125-24-117977 001-40602 24883596 34 711052
2024-04-15 144 xsl144X01/primary_doc.xml 0002002698-24-000109 001-40602 24843464 33 6335
2024-03-28 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-24-080630 001-40602 24799085 34 453528 1 1
2024-03-27 10-K 10-K 0000950170-24-037193 001-40602 24790795 34 50954615 1 1
2024-03-27 8-K 8-K 2.02,9.01 0000950170-24-037161 001-40602 24790571 34 310088 1 1
2024-03-15 144 xsl144X01/primary_doc.xml 0002007317-24-000423 001-40602 24753833 33 6300
2024-02-15 144 xsl144X01/primary_doc.xml 0002007317-24-000128 001-40602 24643232 33 6291
2024-02-14 SC 13G armistice-eras123123.htm 0001172661-24-001348 005-92728 24636929 34 90654
2024-02-13 SC 13G/A SC 13G/A 0001193125-24-034344 005-92728 24631399 34 71755
2024-02-07 4 FORM 4 SUBMISSION 0001209191-24-002968 5562
2024-02-07 4 FORM 4 SUBMISSION 0001209191-24-002967 5493
2024-02-07 4 FORM 4 SUBMISSION 0001209191-24-002966 5490
2024-02-07 4 FORM 4 SUBMISSION 0001209191-24-002965 5498
2024-01-30 SC 13D/A AMENDMENT NO. 3 0000929638-24-000306 005-92728 24578774 34 96432
2024-01-16 144 xsl144X01/primary_doc.xml 0001971857-24-000070 001-40602 24534580 33 6291
2024-01-09 8-K 8-K 7.01,9.01 0000950170-24-003199 001-40602 24521900 34 24751793 1 1
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000272 5811
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000271 5818
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000270 5745
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000269 5814
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000268 5807
2023-12-18 4 FORM 4 SUBMISSION 0001209191-23-058912 4946
2023-12-18 4 FORM 4 SUBMISSION 0001209191-23-058910 4941
2023-12-15 144 xsl144X01/primary_doc.xml 0002002698-23-000116 001-40602 231489672 33 6210
2023-12-11 8-K 8-K 8.01 0000950170-23-069212 001-40602 231477072 34 159174 1 1
2023-12-08 4 FORM 4 SUBMISSION 0001209191-23-057833 5508
2023-12-06 4 FORM 4 SUBMISSION 0001209191-23-057681 8241
2023-12-04 4 FORM 4 SUBMISSION 0001209191-23-057297 5173
2023-11-28 8-K 8-K 8.01,9.01 0000950170-23-066250 001-40602 231442138 34 555938 1 1
2023-11-15 144 xsl144X01/primary_doc.xml 0001971857-23-000859 001-40602 231409690 33 6211
2023-11-09 10-Q 10-Q 0000950170-23-062094 001-40602 231392797 34 10662665 1 1
2023-11-09 8-K 8-K 2.02,9.01 0000950170-23-062003 001-40602 231392249 34 341040 1 1
2023-10-16 144 xsl144X01/primary_doc.xml 0001971857-23-000752 001-40602 231326835 33 6208
2023-10-10 4 FORM 4 SUBMISSION 0001209191-23-052403 6325
2023-09-15 144 xsl144X01/primary_doc.xml 0001971857-23-000680 001-40602 231258331 33 6255
2023-08-29 8-K 8-K 8.01 0000950170-23-045056 001-40602 231221941 34 175055 1 1
2023-08-15 144 xsl144X01/primary_doc.xml 0001971857-23-000530 001-40602 231174243 33 6250
2023-08-10 10-Q 10-Q 0000950170-23-041333 001-40602 231159532 34 11943161 1 1
2023-08-10 8-K 8-K 2.02,9.01 0000950170-23-041299 001-40602 231159298 34 392675 1 1
2023-07-17 144 xsl144X01/primary_doc.xml 0001971857-23-000393 001-40602 231090965 33 6202
2023-06-27 8-K 8-K 5.07 0000950170-23-030108 001-40602 231047341 34 205806 1 1
2023-06-26 4 xslF345X04/form4.xml 0000929638-23-001787 14655
2023-06-26 4 FORM 4 SUBMISSION 0001209191-23-039589 5372
2023-06-26 4 FORM 4 SUBMISSION 0001209191-23-039588 5378
2023-06-26 4 FORM 4 SUBMISSION 0001209191-23-039587 5208
2023-06-26 4/A FORM 4/A SUBMISSION 0001209191-23-039586 5116
2023-06-26 4 FORM 4 SUBMISSION 0001209191-23-039585 5374
2023-06-26 4 FORM 4 SUBMISSION 0001209191-23-039584 5374
2023-06-26 4 FORM 4 SUBMISSION 0001209191-23-039583 5367
2023-06-26 4 FORM 4 SUBMISSION 0001209191-23-039582 5371
2023-06-08 4 FORM 4 SUBMISSION 0001209191-23-035590 6323
2023-06-05 8-K 8-K 8.01,9.01 0000950170-23-026427 001-40602 23993631 34 20445676 1 1
2023-05-25 8-K 8-K 8.01 0000950170-23-024292 001-40602 23961947 34 181713 1 1
2023-05-15 10-Q 10-Q 0000950170-23-022282 001-40602 23924159 34 12643313 1 1
2023-05-15 8-K 8-K 2.02,9.01 0000950170-23-022194 001-40602 23922098 34 348233 1 1
2023-05-01 ARS ARS 0001193125-23-127932 001-40602 23869263 34 16673589
2023-04-28 DEFA14A DEFA14A 0001193125-23-127078 001-40602 23866812 34 43359
2023-04-28 DEF 14A DEF 14A 0001193125-23-127025 001-40602 23866565 34 533330
2023-04-19 8-K 8-K 8.01 0000950170-23-013370 001-40602 23828579 34 177307 1 1
2023-04-13 4 FORM 4 SUBMISSION 0001209191-23-024257 5384
2023-04-13 3 FORM 3 SUBMISSION 0001209191-23-024255 5494
2023-04-11 4 FORM 4 SUBMISSION 0001209191-23-023955 5172
2023-04-10 8-K 8-K 5.02 0000950170-23-012240 001-40602 23809787 34 180331 1 1
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021458 6322
2023-03-23 10-K 10-K 0000950170-23-009496 001-40602 23756396 34 114617683 1 1
2023-03-23 8-K 8-K 2.02,9.01 0000950170-23-009478 001-40602 23756244 34 419748 1 1
2023-03-10 SC 13G/A filing.txt 0000315066-23-002204 005-92728 23721863 34 8043
2023-02-15 5 FORM 5 SUBMISSION 0000899243-23-005182 6709
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-039199 005-92728 23629730 34 73565
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021581 005-92728 23628983 34 126195
2023-02-09 SC 13G/A filing.txt 0000315066-23-001612 005-92728 23602300 34 8028
2023-02-09 8-K 8-K 8.01,9.01 0001193125-23-028869 001-40602 23600873 34 621488 1 1
2023-02-03 4 FORM 4 SUBMISSION 0001209191-23-006482 5432
2023-02-03 4 FORM 4 SUBMISSION 0001209191-23-006481 8767
2023-02-03 4 FORM 4 SUBMISSION 0001209191-23-006480 8749
2023-02-03 4 FORM 4 SUBMISSION 0001209191-23-006479 8748
2023-01-10 4 FORM 4 SUBMISSION 0001209191-23-002802 6290
2023-01-09 8-K 8-K 7.01,9.01 0001193125-23-004264 001-40602 23516859 34 34156917 1 1
2022-12-22 4 FORM 4 SUBMISSION 0001209191-22-062537 5475
2022-12-22 4 FORM 4 SUBMISSION 0001209191-22-062536 5716
2022-12-21 4/A xslF345X03/form4.xml 0000929638-22-001904 13646
2022-12-21 SC 13D/A cormorant_sc13d.htm 0000929638-22-001903 005-92728 221478805 34 90305
2022-12-20 4 xslF345X03/form4.xml 0000929638-22-001901 13308
2022-12-19 SC 13G SC 13G 0001104659-22-128252 005-92728 221471368 34 109617
2022-12-15 4 FORM 4 SUBMISSION 0001209191-22-061461 5141
2022-12-15 4 FORM 4 SUBMISSION 0001209191-22-061352 6290
2022-12-09 8-K 8-K 3.02,8.01,9.01 0001193125-22-301902 001-40602 221455715 34 468437 1 1
2022-12-09 424B5 424B5 0001193125-22-301897 333-266802 221455679 33 426009
2022-12-09 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-22-301402 001-40602 221453643 34 39914437 1 1
2022-11-09 10-Q 10-Q 0000950170-22-023926 001-40602 221373190 34 11799211 1 1
2022-11-09 8-K 8-K 2.02,9.01 0000950170-22-023851 001-40602 221372657 34 419543 1 1
2022-09-07 8-K 8-K 8.01,9.01 0001193125-22-240127 001-40602 221231903 34 31034093 1 1
2022-09-06 SC 13G SC 13G 0001104659-22-097847 005-92728 221228250 34 137729
2022-08-18 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-08-18 16:00:00 9999999995-22-002436 333-266802 221178844 33 1676
2022-08-16 CORRESP filename1.htm 0001193125-22-222335 6609
2022-08-15 UPLOAD filename1.pdf 0000000000-22-008665 40093
2022-08-11 S-3 S-3 0001193125-22-218726 333-266802 221156993 33 1017024
2022-08-11 10-Q 10-Q 0000950170-22-016907 001-40602 221156265 34 10967996 1 1
2022-08-11 8-K 8-K 2.02,9.01 0000950170-22-016874 001-40602 221155984 34 397697 1 1
2022-07-06 4 FORM 4 SUBMISSION 0001209191-22-041388 7023
2022-06-24 4 FORM 4 0001567619-22-013362 8517
2022-06-24 8-K 8-K 5.07 0000950170-22-012066 001-40602 221037294 34 202948 1 1
2022-06-24 4 FORM 4 SUBMISSION 0001209191-22-039106 5340
2022-06-24 4 FORM 4 SUBMISSION 0001209191-22-039105 5346
2022-06-24 4 FORM 4 SUBMISSION 0001209191-22-039104 5342
2022-06-24 4 FORM 4 SUBMISSION 0001209191-22-039103 5342
2022-06-24 4 FORM 4 SUBMISSION 0001209191-22-039102 5335
2022-06-24 4 FORM 4 SUBMISSION 0001209191-22-039101 5339
2022-05-12 10-Q 10-Q 0000950170-22-009720 001-40602 22918432 34 12478427 1 1
2022-05-12 8-K 8-K 2.02,9.01 0000950170-22-009671 001-40602 22917936 34 331535 1 1
2022-04-28 DEFA14A DEFA14A 0001193125-22-127631 001-40602 22866879 34 640093
2022-04-28 DEF 14A DEF 14A 0001193125-22-127567 001-40602 22866674 34 1052211
2022-04-27 4 FORM 4 SUBMISSION 0001209191-22-025841 5223
2022-04-27 3 FORM 3 SUBMISSION 0001209191-22-025833 7427
2022-04-27 8-K 8-K 5.02 0000950170-22-006366 001-40602 22859501 34 207838 1 1
2022-03-24 10-K 10-K 0000950170-22-004557 001-40602 22766800 34 70810129 1 1
2022-03-24 8-K 8-K 2.02,9.01 0000950170-22-004546 001-40602 22766600 34 389954 1 1
2022-03-18 SC 13G SC 13G 0001654954-22-003451 005-92728 22753267 34 111180
2022-02-14 SC 13G SC 13G 0001193125-22-037531 005-92728 22623327 34 78631
2022-02-10 SC 13G ARCH VENTURE FUND X, L.P. - ERASCA, INC. -- SCH 13G 0001072613-22-000078 005-92728 22615110 34 292495
2022-02-03 4 FORM 4 SUBMISSION 0001209191-22-007069 7126
2022-02-03 4 FORM 4 SUBMISSION 0001209191-22-007065 7128
2022-02-03 4 FORM 4 SUBMISSION 0001209191-22-007062 5436
2022-02-03 4 FORM 4 SUBMISSION 0001209191-22-007054 7146
2022-01-10 SC 13G filing.txt 0000315066-22-000042 005-92728 22520722 34 8372
2021-11-23 8-K 8-K 1.01 0000950170-21-004876 001-40602 211439635 34 166799 1 1
2021-11-10 10-Q 10-Q 0000950170-21-004131 001-40602 211397317 34 11594977 1 1
2021-11-10 8-K 8-K 2.02,9.01 0000950170-21-004113 001-40602 211397076 34 379223 1 1
2021-08-26 10-Q 10-Q 0000950170-21-001573 001-40602 211213001 34 11551789 1 1
2021-08-26 8-K 8-K 2.02,9.01 0001193125-21-257579 001-40602 211212490 34 74946
2021-08-10 4 FORM 4 0001567619-21-014882 10092
2021-08-10 SC 13D/A cormorant_sc13d.htm 0000929638-21-000990 005-92728 211159810 34 89719
2021-07-30 SC 13D cormorant_sc13d.htm 0000929638-21-000959 005-92728 211132396 34 115170
2021-07-22 4 FORM 4 0001567619-21-013838 22558
2021-07-20 4 FORM 4 SUBMISSION 0000899243-21-029085 19667
2021-07-20 4 FORM 4 SUBMISSION 0000899243-21-029084 4482
2021-07-20 4 FORM 4 SUBMISSION 0000899243-21-029082 11494
2021-07-20 4 FORM 4 SUBMISSION 0000899243-21-029077 34927
2021-07-20 4 FORM 4 SUBMISSION 0000899243-21-029068 4464
2021-07-20 4 FORM 4 SUBMISSION 0000899243-21-029060 4470
2021-07-20 4 FORM 4 SUBMISSION 0000899243-21-029053 4464
2021-07-20 8-K 8-K 5.03,8.01,9.01 0001193125-21-219642 001-40602 211101293 34 245391
2021-07-16 3/A FORM 3/A 0001567619-21-013592 10128
2021-07-16 S-8 S-8 0001193125-21-217570 333-257988 211096237 33 98331
2021-07-16 424B4 424B4 0001193125-21-217534 333-257436 211096102 33 13000926
2021-07-15 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-07-15 16:00:00 9999999995-21-002792 333-257436 211094197 33 1676
2021-07-15 3 FORM 3 SUBMISSION 0000899243-21-028587 10076
2021-07-15 3 FORM 3 SUBMISSION 0000899243-21-028586 9393
2021-07-15 3 FORM 3 SUBMISSION 0000899243-21-028585 11845
2021-07-15 3 FORM 3 SUBMISSION 0000899243-21-028581 10169
2021-07-15 3 FORM 3 SUBMISSION 0000899243-21-028580 8894
2021-07-15 3 FORM 3 SUBMISSION 0000899243-21-028579 13666
2021-07-15 3 FORM 3 SUBMISSION 0000899243-21-028573 29530
2021-07-15 3 FORM 3 SUBMISSION 0000899243-21-028572 10481
2021-07-15 3 FORM 3 SUBMISSION 0000899243-21-028571 12055
2021-07-15 3 FORM 3 SUBMISSION 0000899243-21-028567 9384
2021-07-15 3 FORM 3 SUBMISSION 0000899243-21-028563 24925
2021-07-15 S-1MEF S-1MEF 0001193125-21-216695 333-257937 211093897 33 41714
2021-07-15 3 FORM 3 0001567619-21-013499 14140
2021-07-15 CERT 8ACERT_ERAS.pdf 0001354457-21-000794 001-40602 211091904 34 161325
2021-07-13 SEC STAFF LETTER filename1.pdf 9999999997-21-004099 271766
2021-07-13 8-A12B 8-A12B 0001193125-21-214084 001-40602 211087920 34 13744
2021-07-13 CORRESP filename1.htm 0001193125-21-214077 11468
2021-07-13 CORRESP filename1.htm 0001193125-21-214069 7909
2021-07-12 CORRESP filename1.htm 0001193125-21-212365 27251
2021-07-12 S-1/A S-1/A 0001193125-21-212361 333-257436 211084186 33 14223173
2021-07-09 UPLOAD filename1.pdf 0000000000-21-008531 47257
2021-06-28 CORRESP filename1.htm 0001193125-21-201587 108284
2021-06-25 CORRESP filename1.htm 0001193125-21-200549 44712
2021-06-25 S-1 S-1 0001193125-21-200537 333-257436 211048836 33 17529554
2021-06-21 UPLOAD filename1.pdf 0000000000-21-007562 49875
2021-06-09 DRSLTR filename1.htm 0000950123-21-007701 53590
2021-06-09 DRS/A filename1.htm 0000950123-21-007700 377-04809 211006022 33 13031887
2021-06-02 SEC STAFF LETTER filename1.pdf 9999999997-21-003324 272587
2021-06-02 UPLOAD filename1.pdf 0000000000-21-006819 56750
2021-05-07 DRS filename1.htm 0000950123-21-005597 377-04809 21903930 33 15221075
2020-04-30 D xslFormDX01/primary_doc.xml 06b 0001567619-20-008665 021-366079 20835071 33 9364
2019-03-11 D/A xslFormDX01/primary_doc.xml 06b 0001567619-19-006548 021-330625 19672156 33 9484
2019-01-15 D xslFormDX01/primary_doc.xml 06b 0001567619-19-001152 021-330625 19527252 33 8628

Latest XBRL company facts

One latest value per concept from companyfacts (205 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 350.96M 2026-11-05 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
dei EntityPublicFloat Entity Public Float USD 316.40M 2025-06-30 2025 FY 10-K 2026-03-12 0001193125-26-104150
ffd NetFeeAmt NetFeeAmt USD 15,579.29 2026-08-10 S-8 2026-08-11 0001193125-26-344845
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 632.50M 2026-07-14 424B5 2026-07-14 0001193125-26-303352
ffd TtlFeeAmt TtlFeeAmt USD 15,579.29 2026-08-10 S-8 2026-08-11 0001193125-26-344845
ffd TtlOfferingAmt TtlOfferingAmt USD 112.81M 2026-08-10 S-8 2026-08-11 0001193125-26-344845
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-10 S-8 2026-08-11 0001193125-26-344845
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-07-14 424B5 2026-07-14 0001193125-26-303352
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.83M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 3.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 10.46M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 34.57M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 261,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 14.73M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -4.18M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 2.09B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 11.93M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 30.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 58.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap Assets Assets USD 998.94M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap AssetsCurrent Assets, Current USD 655.19M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 4.19M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 833.05M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 828.86M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 118.96M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 947.80M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 119.37M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 119.37M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 45.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 81.14M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 800.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 350.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 350.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap CommonStockValue Common Stock, Value, Issued USD 35,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -283.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 340.80M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009496
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Current USD 5.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 14.98M 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125481
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 4,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125481
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions Position 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 813.88M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 4.19M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 813.88M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 4.19M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Position 114 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 11.30M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009496
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 32.51M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 253.51M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 127.33M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 3.49M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 23.91M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 10.17M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 242.21M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 3.17M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 857,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.03 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 2.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.87 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.31 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009720
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.87 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.196 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.016 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.006 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042682
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.027 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 6.31M 2021-06-30 2021 Q2 10-Q 2021-08-26 0000950170-21-001573
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 0 2021-12-31 2021 FY 10-K 2022-03-24 0000950170-22-004557
us-gaap ForeignIncomeTaxExpenseBenefitContinuingOperations Foreign Income Tax Expense (Benefit), Continuing Operations USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 34.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-037193
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -124.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -124.55M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -51,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 72,000 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-26 0000950170-21-001573
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 24.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -2,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -26.16M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 433,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 672,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 3.42M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 2.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 16.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap LandSubjectToGroundLeases Land Subject to Ground Leases sqft 16,153 2018-12-31 2021 Q3 10-Q 2021-11-10 0000950170-21-004131
us-gaap LeaseCost Lease, Cost USD 6.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 55.86M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 15.65M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 9.20M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 9.88M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 9.88M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 9.57M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 9.28M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 2.29M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 12.45M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap Liabilities Liabilities USD 82.20M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 998.94M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap LiabilitiesCurrent Liabilities, Current USD 43.99M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap LongTermInvestments Long-term Investments USD 44.77M 2021-12-31 2021 FY 10-K 2022-03-24 0000950170-22-004557
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap LossContingencyNumberOfPlaintiffs Loss Contingency, Number of Plaintiffs Litigation 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-24 0000950170-22-004557
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 524.74M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 304.12M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss USD 47,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 845.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -712.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -87.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -278.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 16.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-037193
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap OperatingExpenses Operating Expenses USD 295.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -295.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap OperatingLeaseCost Operating Lease, Cost USD 5.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 43.41M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 5.59M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 37.81M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap OperatingLeasePayments Operating Lease, Payments USD 4.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 26.66M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.09 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 396,000 2024-06-30 2024 Q2 10-Q 2024-08-12 0000950170-24-095437
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.22M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -4.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -2.94M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 392,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 115,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 22,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001193125-26-216788
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 54.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap PaymentsToAcquireEquitySecuritiesFvNi PaymentsToAcquireEquitySecuritiesFvNi USD 157,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 150.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 105.81M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-24 0000950170-22-004557
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 778.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 123,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 80.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 11.50M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 317.00M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009496
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 891.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 119.39M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009496
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 43.60M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 114.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 261.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 60.11M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-24 0000950170-22-004557
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 100.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 8.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -278.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 26.06M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 11.33M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 110.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 2.00M 2022-01-01 2022-06-30 2023 Q2 10-Q 2023-08-10 0000950170-23-041333
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 408,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 408,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.17B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 22.70M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-27 0000950170-24-037193
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 30.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009720
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.86 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009720
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.859 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009720
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.017 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009720
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.015 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009720
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2020-04-01 2020-06-30 2021 Q2 10-Q 2021-08-26 0000950170-21-001573
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 91,144 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009720
us-gaap ShortTermInvestments Short-term Investments USD 53.99M 2021-12-31 2021 FY 10-K 2022-03-24 0000950170-22-004557
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-037193
us-gaap StateAndLocalIncomeTaxExpenseBenefitContinuingOperations State and Local Income Tax Expense (Benefit), Continuing Operations USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 916.74M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 1.2 2021-07-09 2022 FY 10-K 2023-03-23 0000950170-23-009496
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 1.68M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009496
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 340.80M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009496
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 769,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 3.65M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap SubleaseIncome Sublease Income USD 2.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2021-06-30 2021 Q2 10-Q 2021-08-26 0000950170-21-001573
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 97.62M 2021-06-30 2021 Q2 10-Q 2021-08-26 0000950170-21-001573
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 6.51M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 862,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 99,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-037193
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 6.00M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 62.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104150
us-gaap VariableLeaseCost Variable Lease, Cost USD 2.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 320.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 119.49M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009720
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 320.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458289

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →